Physician profile
Michael R Beer
NPI 1104867449
$1,111.99
in general payments reported to CMS, 2019-2025
17 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $154 · 2021: $295 · 2022: $216 · 2023: $50.62 · 2024: $84.02 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.05 | 2021-2025 | Lupron Depot |
| Astellas Pharma US INC | $167.36 | 2019-2022 | |
| Boston Scientific Corporation | $122.18 | 2020-2025 | Spaceoar Vue System - 10ml |
| C. R. Bard, INC. & Subsidiaries | $87.49 | 2021 | |
| Pfizer INC. | $78.95 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $70.32 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $56.38 | 2019-2021 | |
| Medtronic, INC. | $50.67 | 2022 | |
| Allergan, INC. | $41.48 | 2019-2020 | |
| Olympus America INC. | $36.23 | 2019 | |
| Coloplast Corp | $31.53 | 2021 | |
| Dendreon Pharmaceuticals LLC | $23.17 | 2021 | |
| Blue Earth Diagnostics | $22.72 | 2020 | |
| Myriad Genetic Laboratories, INC. | $18.96 | 2022 | |
| Laborie Medical Technologies Corp. | $16.95 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Metuchen Pharmaceuticals | $14.09 | 2020 | |
| Axonics, INC. | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Beer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.